Experimental intracameral injection of vancomycin microparticles in rabbits

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 8, 2010, Pages 4125-4132

  Kodjikian, Laurent ^a,b   Couprie, Jérémy ^a   Hachicha, Walid ^c   Timour, Quadiri ^b   Devouassoux, Mojgan ^a   Builles, Nicolas ^d   Hartmann, Daniel ^b   Fessi, Hatem ^c  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ LYON 1   (France)

^d HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; POLYGLACTIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BACTERIUM CONTAMINATION; BLEPHARITIS; CELL COUNT; CELL DEATH; COLONY FORMATION; CONJUNCTIVITIS; CONTROLLED STUDY; CORNEA CELL; CORNEA DISEASE; DISEASE EXACERBATION; DRUG AQUEOUS HUMOR LEVEL; DRUG EFFICACY; DRUG EYE LEVEL; DRUG HALF LIFE; DRUG TISSUE LEVEL; ENDOPHTHALMITIS; EYE TOXICITY; HISTOPATHOLOGY; IN VIVO STUDY; INFECTION RISK; IRITIS; LENS IMPLANT; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RABBIT; RETINA DISEASE; RETINITIS; RISK REDUCTION; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VITREOUS DISEASE; ANIMAL; AQUEOUS HUMOR; BACTERIAL EYE INFECTION; BIOAVAILABILITY; CORNEA ENDOTHELIUM; DISEASE MODEL; DRUG EFFECT; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INJECTION; IRIS; ISOLATION AND PURIFICATION; LENS IMPLANTATION; METABOLISM; MICROBIOLOGY; PARTICLE SIZE; PATHOLOGY; RETINA; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTERIOR CHAMBER; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CELL COUNT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; ENDOPHTHALMITIS; ENDOTHELIUM, CORNEAL; EYE INFECTIONS, BACTERIAL; HALF-LIFE; INJECTIONS; IRIS; LENS IMPLANTATION, INTRAOCULAR; LENSES, INTRAOCULAR; MALE; PARTICLE SIZE; POLYGLACTIN 910; RABBITS; RETINA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN;

EID: 77955866847     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4694     Document Type: Article

References (22)

1. Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ. Intracameral Vigamox (moxifloxacin 0.5%) is nontoxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol. 2005;140:497-504.
2. Maloof A, Saw V. Prophylactic intracameral vancomycin. J Cataract Refract Surg. 2004;30:1610-1611.
3. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime: efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg. 2002;28:1977-1981.
4. Gills JP. Filters and antibiotics in irrigating solution for cataract surgery. J Cataract Refract Surg. 1991;17:385.
5. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. The role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98:639-649.
6. Barry P, Sea DVL, Phila GGD, Lees F, Peterson M, Revie CW. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006;32:407-410.
7. Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology. 1998;105: 1004-1010.
8. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol. 1998;43:193-224.
9. Salvanet-Bouccara A, Forestier F, Coscas G, Adenis JP, Denis F. Endophtalmies bactériennes; résultats ophtalmologique d'une enquête prospective multicentrique nationale. J Fr Ophtalmol. 1992; 15:669-678.
10. Endophtalmitis Study Group, European Society of Cataract and Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007; 33:978-988.
11. Fernández-Rubio E, Urcelay JL, Cuesta-Rodriguez T. The antibiotic resistance pattern of conjunctival bacteria: a key for designing a cataract surgery prophylaxis. Eye. 2009;23:1321-1328.
12. Wejde G, Montan P, Lundstrom M, Stenevi U. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001. Acta Ophthalmol Scand. 2005;83:7-10.
13. Miño de Kaspar H, Koss MJ, He L, Blumenkranz MS, Ta CN. Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am J Ophthalmol. 2005;139:730-733.
14. Gordon YJ. Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes? Am J Ophthalmol. 2001;131:371-376.
15. Kodjikian L, Renaud FNR, Roques C, et al. In vitro influence of vancomycin on adhesion of a Staphylococcus epidermidis strain encoding intercellular adhesion locus ica to intraocular lenses. J Cataract Refract Surg. 2005;31:1050-1058.
16. Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur J Pharm Biopharm. 2004; 57:207-212.
17. Hachicha W, Fessi H, Casoli-Bergeron E, et al. In vitro efficacy of newly designed vancomycin-based microparticles. J Cataract Refract Surg. 2007;33:699-705.
18. Hachicha W, Kodjikian L, Fessi H. Preparation of vancomycin microparticles: importance of preparation conditions. Int J Pharm. 2006;324:176-184.
19. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135-138.
20. Murphy CC, Nicholson S, Quah SA Batterbury M, Neal T, Kaye SB. Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery. Br J Ophthalmol. 2007;91:1350-1353.
21. Yoeruek E, Spitzer MS, Saygili O et al. Comparison of in vitro safety profiles of vancomycin and céfuroxime on human corneal endothelial cells for intracameral use. J Cataract Refract Surg. 2008; 34:2139-2145.
22. Axer-Siegel R, Stiebel-Kalish H, Rosenblatt I Strassmann E, Yassur Y, Weinberger D. Cystoid macular oedema after cataract surgery with intraocular vancomycin. Ophthalmology. 1999;106:1660-1664.